LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 45.25 | 84.90 | 26 | 4539 | 0.0057 | -0.1863 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 45.25 | 84.90 | 845 | 4539 | 0.1861 | 0.4922 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 45.25 | 84.90 | 202 | 4539 | 0.0445 | 0.1630 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 45.25 | 84.90 | 1056 | 4539 | 0.2326 | 0.5513 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.95 | 84.90 | 51 | 4952 | 0.0103 | -0.0832 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.95 | 84.90 | 830 | 4952 | 0.1676 | 0.4750 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.95 | 84.90 | 233 | 4952 | 0.0470 | 0.1878 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.95 | 84.90 | 1032 | 4952 | 0.2084 | 0.5308 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 48.65 | 84.90 | 25 | 5328 | 0.0047 | -0.1851 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 48.65 | 84.90 | 799 | 5328 | 0.1499 | 0.4556 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 48.65 | 84.90 | 228 | 5328 | 0.0428 | 0.1799 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 48.65 | 84.90 | 1092 | 5328 | 0.2049 | 0.5338 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 50.36 | 84.90 | 32 | 5651 | 0.0057 | -0.1488 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 50.36 | 84.90 | 809 | 5651 | 0.1432 | 0.4509 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 50.36 | 84.90 | 288 | 5651 | 0.0510 | 0.2235 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 50.36 | 84.90 | 1121 | 5651 | 0.1984 | 0.5312 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 52.06 | 84.90 | 46 | 5990 | 0.0077 | -0.0950 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 52.06 | 84.90 | 786 | 5990 | 0.1312 | 0.4368 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 52.06 | 84.90 | 511 | 5990 | 0.0853 | 0.3395 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 52.06 | 84.90 | 1036 | 5990 | 0.1729 | 0.5029 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 84.90 | 34 | 6252 | 0.0054 | -0.1372 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 84.90 | 837 | 6252 | 0.1339 | 0.4462 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 84.90 | 803 | 6252 | 0.1284 | 0.4366 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 84.90 | 1117 | 6252 | 0.1786 | 0.5151 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 55.48 | 84.90 | 42 | 6567 | 0.0064 | -0.1061 | MN20160318_Q02 | E14 |